klacid 250mg film-coated tablets
abbott laboratories limited - clarithromycin 250 mg - film-coated tablet
klacid 500mg film-coated tablets
abbott laboratories limited - clarithromycin 500 mg - film-coated tablet
klacid xl 500mg modified-release tablets
abbott laboratories limited - clarithromycin 500 mg - modified-release tablet
miocamen
a. menarini industrie farmaceutiche riunite s.r.l. via sette santi 3, 50131, florence, italy - midecamycin - coated tablet - midecamycin 600 mg - antibacterials for systemic use
miocamen
a. menarini industrie farmaceutiche riunite s.r.l. via sette santi 3, 50131, florence, italy - midecamycin - granules for oral suspension - midecamycin 50 mg/ml - antibacterials for systemic use
kenso agcare bifenthrin termiticide & insecticide
kenso corporation (m) sdn. bhd. - bifenthrin; n-methyl-2-pyrrolidone; liquid hydrocarbon - emulsifiable concentrate - bifenthrin pyrethroid active 100.0 g/l; n-methyl-2-pyrrolidone solvent other 50.0 g/l; liquid hydrocarbon solvent other 567.5 g/l - insecticide
venom 240 sc insecticide
adama australia pty limited - bifenthrin - suspension concentrate - bifenthrin pyrethroid active 240.0 g/l - miticide
poliomyelitis (live) vaccine type i type iii oral drops
china sinopharm international corporation 4, huixindongjie, chaoyang district, beijing - virus strain polio virus seed (sabin strain) type - oral drops - each dose of 2 drops (0.1ml) contains polio virus - poliomyelitis oral bivalent live attenuated
abraxane
celgene limited, a bristol myers squibb company - paclitaxel 100mg (nanoparticle albumin-bound); - powder for injection - 100 mg - active: paclitaxel 100mg (nanoparticle albumin-bound) excipient: albumin - abraxane is indicated for the treatment of metastatic carcinoma of the breast after failure of anthracycline therapy.
as-paclitaxel
viatris limited - paclitaxel 6 mg/ml - concentrate for injection - 6 mg/ml - active: paclitaxel 6 mg/ml excipient: citric acid ethanol nitrogen polyoxyl 35 castor oil - primary treatment of ovarian cancer in combination with other chemotherapeutic agents treatment of metastatic carcinoma of the ovary after failure of standard therapy